bareMinerals

Manufacturer: Bare Escentuals Beauty Inc.
Effective date: 2011-07-26
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:29:17

Label at a glance#

ProductbareMinerals Well-rested

Active ingredientTitanium Dioxide

Label structure10 sections

Indications and uses

Helps prevent sunburn. Higher SPF gives more sunburn protection.

Dosage and administration

Apply evenly before sun exposure as needed.

Storage and handling

Store at room temperature (59° to 86° F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Titanium Dioxide 20%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Uses

INDICATIONS & USAGE SECTION

Helps prevent sunburn.
Higher SPF gives more sunburn protection.

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

Keep out of Eyes ;
Rinse with water to remove

Stop use and ask a doctor if

OTC - STOP USE SECTION

Rash or irritation developes and lasts.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply evenly before sun exposure as needed.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature (59° to 86° F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Mica, Bismuth Oxychloride, Titanium Dioxide, Iron Oxides.

SPL UNCLASSIFIED SECTION

Distr. By Bare Escentuals Beauty Inc., San Francisco CA 94104 USA

PRINCIPAL DISPLAY PANEL - 2 g Jar Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

bareMinerals Eye Brightener SPF 20

well-rested

2 g / 0.06 Oz.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
98132-162-01	2020-01-31	C162847	48780-1	9d75b9d1-25d1-f424-e053-dadaa90a57ce	Well-Rested
98132-162-02	2020-01-31	C162847	48780-1	9d75b9d1-25d1-f424-e053-dadaa90a57ce	Well-Rested

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
98132-162-01	bareMineralsWell-rested	1.2 g in 1 JAR	POWDER	1.2		1
98132-162-02	bareMineralsWell-rested	2 g in 1 JAR	POWDER	2		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
98132-162	BAREMINERALS WELL-RESTED (TITANIUM DIOXIDE) POWDER [BARE ESCENTUALS BEAUTY INC.]	1	Legacy NDC, 2 package rows	20110823_4b6e4e6d-b172-438d-93d7-4d6025ee1e3e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Titanium Dioxide	ACTIVE INGREDIENT	15FIX9V2JP	1
Titanium Dioxide	ACTIVE MOIETY	15FIX9V2JP	1
Bismuth Oxychloride	INACTIVE INGREDIENT	4ZR792I587	1
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	1
Mica	INACTIVE INGREDIENT	V8A1AW0880	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

bareMinerals Well-rested
Titanium Dioxide
Mica
Bismuth Oxychloride
Ferric Oxide Red

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
98132-162	98132-162-01, 98132-162-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Titanium Dioxide	15FIX9V2JP	ACTIB
Mica	V8A1AW0880	IACT
Bismuth Oxychloride	4ZR792I587	IACT
Ferric Oxide Red	1K09F3G675	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 21 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, EXTENDED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	POWDER, FOR SUSPENSION / ORAL		1 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, COATED PELLETS / ORAL	2 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, DELAYED RELEASE / ORAL		37 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, COATED / ORAL	0.12 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET / ORAL		8 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, DELAYED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	SUSPENSION, EXTENDED RELEASE / ORAL	2.7 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	LOTION / TOPICAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	DROPS / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET / BUCCAL	0.4 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CAPSULE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL	0.15 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED / ORAL		3 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CREAM / TOPICAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
Ferric Oxide Red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, EXTENDED RELEASE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
7b4cf4ec-8db5-4db6-91a2-4dea25f70457			4b6e4e6d-b172-438d-93d7-4d6025ee1e3e	2011-07-26	Warnings	Exact identifier spl id: 7b4cf4ec-8db5-4db6-91a2-4dea25f70457 spl set id: 4b6e4e6d-b172-438d-93d7-4d6025ee1e3e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.